KR20080077625A - 상처 치유 방법 - Google Patents

상처 치유 방법 Download PDF

Info

Publication number
KR20080077625A
KR20080077625A KR1020087014376A KR20087014376A KR20080077625A KR 20080077625 A KR20080077625 A KR 20080077625A KR 1020087014376 A KR1020087014376 A KR 1020087014376A KR 20087014376 A KR20087014376 A KR 20087014376A KR 20080077625 A KR20080077625 A KR 20080077625A
Authority
KR
South Korea
Prior art keywords
euphorbia
wound
yuporeubiah
ingenol
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087014376A
Other languages
English (en)
Korean (ko)
Inventor
스티븐 마틴 옥부른
데이비드 토마스
라이언 모슬리
Original Assignee
페플린 리서치 피티이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005906601A external-priority patent/AU2005906601A0/en
Application filed by 페플린 리서치 피티이 리미티드 filed Critical 페플린 리서치 피티이 리미티드
Publication of KR20080077625A publication Critical patent/KR20080077625A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020087014376A 2005-11-25 2006-11-24 상처 치유 방법 Ceased KR20080077625A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005906601A AU2005906601A0 (en) 2005-11-25 Therapeutic methods and compositions
AU2005906601 2005-11-25

Publications (1)

Publication Number Publication Date
KR20080077625A true KR20080077625A (ko) 2008-08-25

Family

ID=38066849

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087014376A Ceased KR20080077625A (ko) 2005-11-25 2006-11-24 상처 치유 방법

Country Status (9)

Country Link
US (2) US20090215884A1 (https=)
EP (1) EP1965818A4 (https=)
JP (1) JP2009517345A (https=)
KR (1) KR20080077625A (https=)
CN (1) CN101360506A (https=)
BR (1) BRPI0618926A2 (https=)
CA (1) CA2629899A1 (https=)
NZ (1) NZ568168A (https=)
WO (1) WO2007059584A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504726B2 (en) 2009-08-26 2016-11-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
EP1838330A4 (en) 2004-12-13 2010-07-07 Peplin Research Pty Ltd TREATMENT OF SOLID TUMORS
JP5291369B2 (ja) * 2008-03-31 2013-09-18 株式会社ナリス化粧品 ケラチノサイト増殖促進剤
JP5638008B2 (ja) * 2009-02-13 2014-12-10 レオ・ラボラトリーズ・リミテッドＬｅｏ Ｌａｂｏｒａｔｏｒｉｅｓ Ｌｉｍｉｔｅｄ 皮膚治療方法
EP2558435B1 (en) 2010-04-16 2017-06-07 Leo Pharma A/S Orthorhombic crystalline ingenol mebutate
WO2012005876A2 (en) * 2010-06-30 2012-01-12 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
US9402823B2 (en) 2010-12-17 2016-08-02 Leo Laboratories Limited Ingenols for treating seborrheic keratosis
JP2014507396A (ja) * 2010-12-22 2014-03-27 レオ・ラボラトリーズ・リミテッド イノゲノール−３−アシラートｉ
CN103402969A (zh) * 2010-12-22 2013-11-20 利奥实验室有限公司 3-酰基-巨大戟二萜醇ii
RU2572549C2 (ru) * 2010-12-22 2016-01-20 Лео Лэборетериз Лимитед Ингенол-3-ацилаты iii и ингенол-3-карбаматы
WO2012176015A1 (en) * 2011-06-24 2012-12-27 Leo Pharma A/S Methods for treating uv-damaged skin and scc tumors and for removing tattoos with topical ingenol mebutate
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
EP2790670A1 (en) * 2011-12-12 2014-10-22 Leo Laboratories Limited Gel compositions
US20130251782A1 (en) * 2012-03-22 2013-09-26 Leo Laboratories Limited Topical application of ingenol mebutate with occlusion
CA2875461A1 (en) * 2012-06-26 2014-01-03 Xifu Liang 3-o-heteroaryl-ingenol
KR20150027831A (ko) * 2012-07-06 2015-03-12 레오 파마 에이/에스 피부에 활성 성분을 전달하기 위한 막-형성 중합체를 포함하는 국소 조성물
US9962364B2 (en) 2012-12-26 2018-05-08 A-Z Ltd. Wound healing accelerator
US20150366789A1 (en) * 2013-03-13 2015-12-24 Avon Place, Inc. Glochidium wallichianum extracts and methods of use
CN105055448A (zh) * 2015-05-25 2015-11-18 中国人民解放军第三军医大学第一附属医院 铜离子制剂在制备促进皮肤角质形成细胞增殖药物或敷料中的用途
KR20180118795A (ko) * 2016-03-18 2018-10-31 인트렉손 코포레이션 Vii형 콜라겐 결핍증의 치료를 위한 조성물 및 방법
CN106619600B (zh) * 2016-03-28 2019-10-18 中国科学院遗传与发育生物学研究所 巨大戟醇及其衍生物在增强溶酶体生成中的应用
CN115677520B (zh) * 2022-11-18 2024-04-02 扬州大学 一种二萜化合物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809749A (en) * 1971-03-05 1974-05-07 Amazon Natural Drug Co Topical pharmaceutical composition and method employing sap from the tree croton lechleri
DE2902506A1 (de) * 1979-01-23 1980-07-24 Deutsches Krebsforsch Verwendung von nicht oder nur gering irritierenden und/oder promovierenden diterpenalkoholen und von derivaten davon als antineoplastische mittel
US4418064A (en) * 1982-09-29 1983-11-29 The United States Of America As Represented By The Secretary Of Agriculture Chemotherapeutically active maytansinoids: treflorine, trenudine, and N-methyltrenudone
US4560774A (en) * 1982-11-17 1985-12-24 Arizona State University Macrocyclic lactones
US5886017A (en) * 1986-06-11 1999-03-23 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. E.
US5145842A (en) * 1986-06-11 1992-09-08 Alder Research Center Limited Partnership Protein kinase c. modulators. d.
US5886019A (en) * 1986-06-11 1999-03-23 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. F.
US5643948A (en) * 1986-06-11 1997-07-01 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. K.
US5891906A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Polyacetate-derived phorboids having anti-inflammatory and other uses
US5891870A (en) * 1986-06-11 1999-04-06 Procyon Pharmaceuticals, Inc. Protein kinase C modulators Q
US5716968A (en) * 1986-06-11 1998-02-10 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. H.
US5962498A (en) * 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US5750568A (en) * 1986-06-11 1998-05-12 Procyon Pharmaceuticals, Inc. Protein kinase C Modulators. L.
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5317009A (en) * 1991-08-26 1994-05-31 New York University Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
US6593371B1 (en) * 1993-05-19 2003-07-15 Jeff J. Staggs Treatment for wart and related disorders
US5874464A (en) * 1995-01-13 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Conformationally constrained diacylglycerol analogues
US5932613A (en) * 1996-07-03 1999-08-03 Millennium Pharmaceuticals, Inc. Anticancer agents
AUPO864097A0 (en) 1997-08-19 1997-09-11 Peplin Pty Ltd Anti-cancer compounds
DE59901057D1 (de) * 1999-01-29 2002-05-02 Sid Soc Ind De La Doux S A Zerkleinerungsvorrichtung mit wenigstens einer drehenden Welle
KR20020020808A (ko) * 1999-08-13 2002-03-15 스무크 존 질병의 광역학적 치료를 위한 국부투여 약물 및 그 방법
JP2001139468A (ja) * 1999-11-11 2001-05-22 Lead Chemical Co Ltd 抗ウイルス作用を有するホルボール誘導体
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
US6923993B2 (en) * 2001-12-12 2005-08-02 Nicholas J. Donato Process of isolating extract from the Euphorbia obesa plant and methods for using the same
US7390499B2 (en) * 2002-04-26 2008-06-24 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
WO2005043155A1 (en) * 2003-10-21 2005-05-12 Cedars-Sinai Medical Center System and method for the treatment of cancer, including cancers of the central nervous system
EP1628673B1 (en) * 2004-01-01 2007-03-07 Panacea Biotec Limited Pharmaceutical compositions comprising an extract of euphorbia prostrata
BRPI0504797B1 (pt) * 2005-10-27 2020-02-04 Pele Nova Biotecnologia S.A. formulação tópica, método de tratamento cosmético para rejuvenescimento da pele, método de tratamento cosmético e uso de uma formulação

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504726B2 (en) 2009-08-26 2016-11-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US10966918B2 (en) 2009-08-26 2021-04-06 Mary Kay Inc. Topical skin care formulations comprising plant extracts
US11419810B2 (en) 2009-08-26 2022-08-23 Mary Kay Inc. Topical skin care formulations comprising plant extracts

Also Published As

Publication number Publication date
BRPI0618926A2 (pt) 2011-09-13
EP1965818A1 (en) 2008-09-10
US20160317486A1 (en) 2016-11-03
EP1965818A4 (en) 2010-02-17
US20090215884A1 (en) 2009-08-27
CN101360506A (zh) 2009-02-04
CA2629899A1 (en) 2007-05-31
NZ568168A (en) 2012-06-29
JP2009517345A (ja) 2009-04-30
WO2007059584A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
KR20080077625A (ko) 상처 치유 방법
Xie et al. Gastroprotective effect of gamma-aminobutyric acid against ethanol-induced gastric mucosal injury
Miladiyah et al. Ethanolic extract of Anredera cordifolia (Ten.) Steenis leaves improved wound healing in guinea pigs
Cherniack Bugs as Drugs, Part 1: Insects: the" new" alternative medicine for the 21st century
Padwad et al. Effect of leaf extract of Seabuckthorn on lipopolysaccharide induced inflammatory response in murine macrophages
RU2506951C2 (ru) Лечение повреждений, индуцированных вирусом
Wung et al. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation
Tsala et al. Natural wound healing and bioactive natural products
JP6239041B2 (ja) 微生物感染の治療に使用するためのタマリンド種子多糖
KR102601621B1 (ko) 복사나무 추출물을 함유하는 조성물
EA032501B1 (ru) Способы и композиции для содействия заживлению острой раны и хронической раны
Fernandes et al. Healing and cytotoxic effects of Psidium guajava (Myrtaceae) leaf extracts
KR20200104158A (ko) 아쿠아포닉스 재배기술을 이용한 병풀 추출물을 포함하는 화장료 조성물
Pratiwi et al. Studies on anti-inflammatory activity and wound-healing property of secondary metabolite of Anredera cordifolia (Ten.) Steenis leaves: A review
Santoso et al. Histopathological evaluation of wound healing and anti-inflammatory effects of granola potato peel ethanol extract in rat oral mucosa
Bałan et al. Review paper Immunotropic activity of Echinacea. Part I. History and chemical structure
Tessema et al. Evaluation of in vivo wound healing and anti-inflammatory activity of crude extract of the fruits of Brucea antidysentrica in mice
KR20110104625A (ko) 아토피 피부염 예방 및 개선효과를 나타내는 황금 가수분해 추출물의 제조방법 및 이를 이용하여 제조된 화장품
KR101068375B1 (ko) 생지황, 석창포, 고삼, 자초 및 황백의 추출물을 유효성분으로 함유하는 아토피 치료용 조성물
KR102502443B1 (ko) 달맞이꽃의 열수 추출물을 유효성분으로 포함하는 튼살 예방, 개선, 또는 치료를 위한 조성물
TW202228667A (zh) 慢性傷口癒合之二組分組合物
AU2006317523A1 (en) Methods for wound healing
Liberal et al. Anti-Inflammatory Activity of the Honeybee Plant-Derived Products Honey, Pollen and Propolis
Wang et al. Effect of Zaoxiu ointment on wound-healing in experimental second degree burns rats
Potaraju et al. Evaluation of Wound Healing and Anti-inflammatory Activities of Leaves of Ziziphus oenoplia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080613

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20111012

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130501

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20131029

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130501

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I